A. Tanizawa et Y. Pommier, TOPOISOMERASE-I ALTERATION IN A CAMPTOTHECIN-RESISTANT CELL-LINE DERIVED FROM CHINESE-HAMSTER DC3F CELLS IN CULTURE, Cancer research, 52(7), 1992, pp. 1848-1854
Camptothecin-resistant DC3F Chinese hamster lung fibroblast cell lines
were obtained after mutagenic treatment with ethylmethanesulfonate an
d subsequent exposure to 1-mu-M camptothecin (CPT). The most resistant
cell line, which was obtained after exposure to CPT for 10 days, was
designated DC3F/C-10. Comparison of 50% inhibitory concentration value
s after 8-h CPT treatments showed that DC3F/C-10 cells were 134-fold r
esistant to CPT. Resistance was associated with marked reduction of CP
T-induced DNA single-strand breaks and DNA-protein cross-links. This r
eduction was not due to reduced amounts of immunoreactive DNA topoisom
erase I protein, although nuclear extracts from DC3F/C-10 cells had le
ss enzyme catalytic activity than those from DC3F cells. Also, fast pr
otein liquid chromatography-purified DNA topoisomerase I from DC3F/C-1
0 had lower specific catalytic activity than that from DC3F cells. DNA
topoisomerase I from DC3F/C-10 was resistant to inhibition of catalyt
ic activity and induction of DNA cleavage by CPT. These results sugges
t that CPT resistance in DC3F/C-10 cells is due to qualitative alterat
ion of DNA topoisomerase I.